Xiaocui Fang

4PUBLICATIONS
9CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Mar 23, 2026
Multivalent Peptide-Guided EZH2 Degradation Sensitizes Immune Checkpoint Therapy in TNBC.

Minxian Li, Haipeng Zhao, Lilusi Ma

|Jan 23, 2026
Targeted degradation of Pin1 by an antagonistic peptide enhances gemcitabine therapy in pancreatic cancer.

Mengting Chen, Xiangyu Chu, Haipeng Zhao

|Aug 06, 2025
Development of a CXCR4 antagonistic peptide, P12, to suppress pancreatic cancer progress via enhancing T cell responses and sensitizing cells to gemcitabine.

Xin Huang, Hang Wu, Ke Zhu

|Aug 10, 2017
Anti-tumor activity of nanomicelles encapsulating CXCR4 peptide antagonist E5.

Xiaocui Fang, Hanyi Xie, Hongyang Duan

Pageof 1

Frequent Collaborators

2 joint publications

Chen Wang

2 joint publications

Qiaojun Fang

1 joint publications

Tao Wen

1 joint publications

Jian Liu